- Home
- LND vs PROK Comparison
LND vs PROK Comparison
Compare LND & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LND
- PROK
- Stock Information
- Founded
- LND 2005
- PROK 2015
- Country
- LND Brazil
- PROK United States
- Employees
- LND N/A
- PROK N/A
- Industry
- LND Farming/Seeds/Milling
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LND Consumer Staples
- PROK Health Care
- Exchange
- LND Nasdaq
- PROK Nasdaq
- Market Cap
- LND 376.5M
- PROK 417.1M
- IPO Year
- LND 2006
- PROK N/A
- Fundamental
- Price
- LND $3.66
- PROK $3.40
- Analyst Decision
- LND
- PROK Strong Buy
- Analyst Count
- LND 0
- PROK 4
- Target Price
- LND N/A
- PROK $6.25
- AVG Volume (30 Days)
- LND 39.5K
- PROK 2.2M
- Earning Date
- LND 11-10-2025
- PROK 11-11-2025
- Dividend Yield
- LND 3.28%
- PROK N/A
- EPS Growth
- LND N/A
- PROK N/A
- EPS
- LND 0.25
- PROK N/A
- Revenue
- LND $194,084,753.00
- PROK $527,000.00
- Revenue This Year
- LND $40.80
- PROK $471.74
- Revenue Next Year
- LND $5.24
- PROK N/A
- P/E Ratio
- LND $14.38
- PROK N/A
- Revenue Growth
- LND 3.73
- PROK N/A
- 52 Week Low
- LND $3.49
- PROK $0.46
- 52 Week High
- LND $4.39
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- LND 39.61
- PROK 63.04
- Support Level
- LND $3.60
- PROK $3.05
- Resistance Level
- LND $3.78
- PROK $3.45
- Average True Range (ATR)
- LND 0.07
- PROK 0.26
- MACD
- LND 0.00
- PROK 0.01
- Stochastic Oscillator
- LND 30.00
- PROK 90.00
About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)
Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.